Neural stem cells as therapeutic agents for the treatment of hearing loss
Ten percent of the world’s population suffers from hearing loss due to damaged hair cells of the inner ear. Hair cells supply signals that promote the survival of spiral ganglia neurons (SGNs), the next link in the sonic signaling chain. Once the hair cells die, so do the SGNs. Hair cells regenerate at an extremely low rate. Thus, a cell replacement stratagem may offer a more immediate therapy due to the permanent loss of hair cells and SGNs.
Researchers at the University of California, Davis have discovered the existence of a source of replacement cells for both hair cells and SGNs in the lateral wall of the lateral ventricle that can serve as biological implants for the deaf and hard of hearing.
Most forms of sensorineural hearing loss result from irreversible damage of cochlear hair cells which is followed by degeneration of target-deprived spiral ganglia neurons (SGNs). Secondary degeneration of SGNs could severely compromise the efforts to rehabilitate hearing impaired patients with cochlear implants or hair cell regeneration. However, there is limited availability of newly generated SGNs in humans and biological implantation of cells is not therapeutically inefficacious.
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 8,962,314 | 02/24/2015 | 2009-317 |
hearing loss, deafness, cochlea, ependymal cells, hearing restoration, neural stem cells, spiral ganglia neurons, SGN